These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7104356)

  • 1. Determination of elongation factor 2 associated with native mammalian ribosomes.
    Chinali G; Sacchi A; Ferrini U
    Biochim Biophys Acta; 1982 May; 697(2):193-201. PubMed ID: 7104356
    [No Abstract]   [Full Text] [Related]  

  • 2. [The eukaryotic elongation factor EF-2 loses its nonspecific affinity for RNA as a result of ADP ribosylation].
    Bezlepkina TA; Davydova EK; Sitikov AS; Vertiev IuA; Ezepchuk IuV
    Dokl Akad Nauk SSSR; 1984; 278(3):751-4. PubMed ID: 6209075
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS; Davydova EK; Bezlepkina TA; Ovchinnikov LP; Spirin AS
    FEBS Lett; 1984 Oct; 176(2):406-10. PubMed ID: 6208057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of elongation factor 2 with layer ribosomes of dimethylnitrosamine-treated mice.
    Delpino A; Mattei E; Ferrini U
    Chem Biol Interact; 1981 Jul; 36(1):123-7. PubMed ID: 7249148
    [No Abstract]   [Full Text] [Related]  

  • 6. Recognition of elongation factor 2 by diphtheria toxin is not solely defined by the presence of diphthamide.
    Van Ness BG; Barrowclough B; Bodley JW
    FEBS Lett; 1980 Oct; 120(1):4-6. PubMed ID: 7439387
    [No Abstract]   [Full Text] [Related]  

  • 7. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O; Ozdemirli M; Nurten R; Bermek E
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1210-4. PubMed ID: 3094526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
    Riis B; Rattan SI; Clark BF
    J Biochem Biophys Methods; 1989 Oct; 19(4):319-25. PubMed ID: 2693515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elongation factor 2 content of mammalian cells. Assay method and relation to ribosome number.
    Gill DM; Dinius LL
    J Biol Chem; 1973 Jan; 248(2):654-8. PubMed ID: 4346341
    [No Abstract]   [Full Text] [Related]  

  • 10. Ribosomes terminated in vitro are in a tight association with non-phosphorylated elongation factor 2 (eEF-2) and GDP.
    Davydova EK; Malinin NL; Ovchinnikov LP
    Eur J Biochem; 1993 Jul; 215(2):291-6. PubMed ID: 8344297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphtheria toxin.
    Uchida T
    Pharmacol Ther; 1982; 19(1):107-22. PubMed ID: 6763703
    [No Abstract]   [Full Text] [Related]  

  • 12. Elongation-factor-2-induced sensitization of ribosomes to modeccin. Evidence for specific binding of elongation factor 2 to ribosomes in the absence of nucleotides.
    Olsnes S; Abraham AK
    Eur J Biochem; 1979 Feb; 93(3):447-52. PubMed ID: 421687
    [No Abstract]   [Full Text] [Related]  

  • 13. Diphtheria toxin resistance in human lymphoblast lines.
    Gupta RS
    Biochem Biophys Res Commun; 1980 Jun; 94(4):1303-10. PubMed ID: 7396963
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence of formation of a complex between GTP and elongation factor two and the binding of the complex to a specific site on mammalian ribosomes.
    Baliga BS; Munro HN
    Biochim Biophys Acta; 1972 Aug; 277(2):368-83. PubMed ID: 5075290
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics of adenosinediphosphoribosylation of elongation factor 2 in cells exposed to diphtheria toxin.
    Moynihan MR; Pappenheimer AM
    Infect Immun; 1981 May; 32(2):575-82. PubMed ID: 7251138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modifications of the elongation factor 2.
    Balestrieri C; Giovane A; Quagliuolo L; Servillo L
    Adv Exp Med Biol; 1988; 231():627-32. PubMed ID: 3414446
    [No Abstract]   [Full Text] [Related]  

  • 17. Masking of peptidyl transferase activity in polyribosomes.
    Leick VR; Santerre RF; Kaempfer R
    Arch Biochem Biophys; 1975 Aug; 169(2):622-6. PubMed ID: 1101832
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification and characterization of peptide-elongation factor 2 (aEF-2) from an extremely halophilic archaebacterium Halobacterium halobium.
    Saruyama H; Sasaki S
    Eur J Biochem; 1988 Jan; 170(3):499-505. PubMed ID: 3338448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the binding of ADP-ribosylated human translocation factor to ribosomes.
    Bermek E
    Hamatol Bluttransfus; 1974; 14():308-13. PubMed ID: 4448421
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin.
    Chung DW; Collier RJ
    Biochim Biophys Acta; 1977 Aug; 483(2):248-57. PubMed ID: 196649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.